![](https://www.competitionpolicyinternational.com/wp-content/uploads/2023/04/Shutterstock_1396957739-300x180.jpg)
Amgen, Teva Get Can Appeal Sensipar Antitrust Ruling
Amgen and Teva Pharmaceuticals Industries have been granted permission for an expedited appeal in an antitrust case related to Amgen’s
Amgen and Teva Pharmaceuticals Industries have been granted permission for an expedited appeal in an antitrust case related to Amgen’s
A regulator is reportedly looking into JPMorgan Chase’s due diligence on recent acquisitions. The Office of the Comptroller of the Currency (OCC) launched
Former Google head Eric Schmidt opposes a six-month pause of artificial intelligence (AI) experiments. While the concerns about AI are legitimate — and may even be
The US National Football League has requested a federal judge to prevent plaintiffs’ lawyers from seeking documents related to competing
Regulators announced on Thursday that the company responsible for ChatGPT will suggest solutions to address data privacy issues that led
Apple is reportedly unlikely to spend its buildup of cash on a big acquisition. Although there is commonly speculation that the
A federal judge in Los Angeles dismissed Pandora Media’s antitrust case against a group of comedians who had previously sued
The purchase of iRobot by Amazon is under investigation by British antitrust regulators, and the deal is receiving additional scrutiny
On Wednesday, the UK antitrust regulator announced limitations on the amount that Motorola Solutions can charge for the use of
Several startups in India have requested an investigation by the country’s competition watchdog into Google for reportedly violating antitrust rules
© Competition Policy International 2024